文献
J-GLOBAL ID:202202291624133149
整理番号:22A1169987
腫瘍切除後の難治性下垂体腺腫に対するカペシタビン+テモゾロミドの化学療法および血清プロラクチン,IGF-1および成長ホルモンに対する影響【JST・京大機械翻訳】
Chemotherapy of Capecitabine plus Temozolomide for Refractory Pituitary Adenoma after Tumor Resection and Its Impact on Serum Prolactin, IGF-1, and Growth Hormone
著者 (5件):
Wang Xirui
(Third Department of Neurosurgery, Cangzhou Central Hospital, Cangzhou, Hebei Province, China)
,
Hu Changwei
(Third Department of Neurosurgery, Cangzhou Central Hospital, Cangzhou, Hebei Province, China)
,
Li Yabin
(Third Department of Neurosurgery, Cangzhou Central Hospital, Cangzhou, Hebei Province, China)
,
Ren Baowen
(Third Department of Neurosurgery, Cangzhou Central Hospital, Cangzhou, Hebei Province, China)
,
Yin Gangfeng
(Third Department of Neurosurgery, Cangzhou Central Hospital, Cangzhou, Hebei Province, China)
資料名:
Journal of Oncology (Web)
(Journal of Oncology (Web))
巻:
2022
ページ:
Null
発行年:
2022年
JST資料番号:
U7781A
ISSN:
1687-8450
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
イギリス (GBR)
言語:
英語 (EN)